Neurosoft Bioelectronics raises $7.5M seed

◆ Amount

$7.5M

◆ Announced

20 May 2026

◆ Company

◆ Source

◆ The Round

Neurosoft Bioelectronics raised $7.5M in seed funding, announced on 20 May 2026, led by Skybound Venture Capital, with participation from Protocol Labs, IAG Capital Partners, Connecticut Innovations. The round is tracked live by Fusion42 as part of the Raise fund database and the Scout startup database.

◆ About Neurosoft Bioelectronics

Swiss neurotechnology company developing minimally invasive brain-computer interface (BCI) platforms using soft and stretchable neural interfaces. Neurosoft Bioelectronics is based in Switzerland and currently at seed stage, operating in Digital Health, Medtech.

◆ Investors

◆ Investing funds on Raise

• Skybound Venture Capital

◆ Market context

Skybound Venture Capital is profiled on Raise, Fusion42's database of venture funds — where each investor's thesis, cheque size and other tracked backings can be followed. This funding event is a citable node in Fusion42's market graph: it links Neurosoft Bioelectronics's Scout profile to the funds behind the round and to related Wire analysis, and is refreshed from public announcements as the round is confirmed or extended. It is the same live market data Arthur reasons over when benchmarking a founder's own raise against what is closing in the market right now.

◆ Explore the market